Tessera Therapeutics

About Tessera Therapeutics

Tessera Therapeutics is an early-stage biotechnology company focused on Gene Writing™, a genome engineering approach that writes therapeutic messages into the genome to treat diseases at their source. The company develops versatile gene-writing technologies and tissue-targeted non-viral delivery methods to enable genomic alterations where needed, with programs spanning in vivo applications. Its mission is to cure disease by writing in the code of life and expand possibilities in genetic medicine. Based in the life sciences ecosystem associated with Flagship Pioneering, Tessera communicates its work through focused biology, gene writing, and delivery research.